Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep

Loading...
Thumbnail Image

Date

Authors

Hunter, P.
Erasmus, B.J.
Vorster, J.H. (Jan Harm)

Journal Title

Journal ISSN

Volume Title

Publisher

Published jointly by the Agricultural Research Council, ARC-Onderstepoort Veterinary Institute and the Faculty of Veterinary Science, University of Pretoria.

Abstract

A 5-fluorouracil mutagenised Rift Valley fever virus strain, which was shown to be attenuated and immunogenic in cattle and sheep, was evaluated for its ability to cause teratogenic effects in pregnant sheep. A group of 50 sheep at various stages of pregnancy was inoculated with the virus and the pregnancies followed to term. There were two abortions and 14% of the lambs produced by vaccinated ewes showed teratogenic effects, the most prevalent being spinal hypoplasia, hydranencephaly, brachygnathia inferior and arthrygryposis. The foetal malformations of the central nervous and musculo-skeletal systems were mostly consistent with those observed in sheep vaccinated with the attenuated Smithburn RVF strain. The teratogenic effects of MVP12 were not seen in previous experiments by other authors as immunisation of sheep took place in the second to third trimester of pregnancy, when the fetal brain tissue has completed most of its cell division.

Description

The articles have been scanned in colour with a HP Scanjet 5590; 600dpi. Adobe Acrobat v.9 was used to OCR the text and also for the merging and conversion to the final presentation PDF-format.

Keywords

Veterinary medicine, Mutagenised, MVP 12, Rift Valley fever virus (RVFV), Sheep, Teratogenicity

Sustainable Development Goals

Citation

Hunter, P, Erasmus, BJ & Vorster, JH 2002, 'Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep’. Onderstepoort Journal of Veterinary Research, vol. 69, no. 1, pp. 95-98.